3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness.
CONCLUSIONS
3 Tesla (3T) magnetic resonance imaging (MRI) performed 4 h after intravenous gadolinium (Gd) injection provides sufficient anatomic resolution of the inner ear fluid spaces in sudden deafness. The signal intensity ratio (SIR) between the cochlea and cerebellum may be a good indicator of disruption of the blood-labyrinthine barrier.


OBJECTIVE
We evaluated the inner ear 4 h after intravenous Gd injection to determine whether 3T MRI enables the acquisition of images of the affected inner ear in sudden deafness.


METHODS
Ten patients underwent 3T MRI scanning 4 h after intravenous Gd injection. Three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) MRI was performed.


RESULTS
The SIR varied from 0.45 to 2.17 in 11 affected ears and from 0.43 to 1.48 in 9 unaffected ears. The difference of contrast (affected ear vs unaffected ear) could be detected in five of the nine patients with unilateral sudden deafness. The Gd distribution was recognized in the vestibule of 10 affected ears and in the cochlea of 5 affected ears, in which no significant hydrops was observed. In the remaining vestibules and cochleas of affected ears, the Gd enhancement was too faint to evaluate the endolymphatic hydrops.
Tagaya
Mitsuhiko
M
Department of Otorhinolaryngology, Nagoya University, Graduate School of Medicine, Nagoya, Japan. mi-man@ra2.so-net.ne.jp
Teranishi
Masaaki
M
Naganawa
Shinji
S
Iwata
Tomoyuki
T
Yoshida
Tadao
T
Otake
Hironao
H
Nakata
Seiichi
S
Sone
Michihiko
M
Nakashima
Tsutomu
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001301:Audiometry, Pure-Tone; D001309:Auditory Threshold / Q000502:physiology; D002531:Cerebellum / Q000473:pathology; D003051:Cochlea / Q000473:pathology*; D003287:Contrast Media; D004710:Endolymph / Q000502:physiology; D018159:Endolymphatic Hydrops / Q000175:diagnosis / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D005682:Gadolinium; D003639:Hearing Loss, Sudden / Q000175:diagnosis* / Q000473:pathology; D006571:Heterocyclic Compounds; D006801:Humans; D007089:Image Enhancement; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D010498:Perilymph / Q000502:physiology; D012680:Sensitivity and Specificity; D014722:Vestibule, Labyrinth / Q000473:pathology
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium